Citadel Advisors’s CM Life Sciences, Inc. Unit CMLFU Stock Holding History

Citadel Advisors’s Portfolio CMLFU Stock Details CMLFU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-13,557	Closed	-$222K	–	15328
2021 Q2	$222K	Sell	13,557 -12,301	-48%	-$178K	﹤0.01%	11937
2021 Q1	$425K	Buy	+25,858	New	+$453K	﹤0.01%	10046

Citadel Advisors's CMLFU Position: Q3 2021 in Review

Citadel Advisors sold out of CM Life Sciences, Inc. Unit (CMLFU) in Q3 2021, closing a stake of 13,557 shares — an estimated $222K sold.

Citadel Advisors first reported a position in CMLFU in Q1 2021 and held it in 2 quarters. The position peaked at $425K in Q1 2021. 0 funds tracked by Wall St. Rank hold CMLFU as of Q3 2021.

Citadel Advisors reported no remaining CM Life Sciences, Inc. Unit position as of Q3 2021 after selling out during the quarter.
Citadel Advisors sold 13,557 CM Life Sciences, Inc. Unit shares in Q3 2021, an estimated $222K.
Citadel Advisors first reported a position in CM Life Sciences, Inc. Unit in Q1 2021 and held it in 2 quarters.
Citadel Advisors's CM Life Sciences, Inc. Unit position peaked at $425K in Q1 2021.
0 funds tracked by Wall St. Rank held CM Life Sciences, Inc. Unit as of Q3 2021.

Based on Citadel Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.